Invesco Pharmaceuticals ETF
PJP
106 hedge funds and large institutions have $318M invested in Invesco Pharmaceuticals ETF in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 37 increasing their positions, 41 reducing their positions, and 12 closing their positions.
2% more call options, than puts
Call options by funds: $902K | Put options by funds: $882K
10% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 41
2.93% less ownership
Funds ownership: 21.72% → 18.78% (-2.9%)
4% less funds holding
Funds holding: 110 → 106 (-4)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
28% less capital invested
Capital invested by funds: $440M → $318M (-$122M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$4.03M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.58M |
| 3 |
JWM
Jackson Wealth Management
Lake Mary,
Florida
|
+$3.52M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$3.13M |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$2.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$19.7M |
| 2 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$18.2M |
| 3 |
NCM
Niemann Capital Management
Stateline,
Nevada
|
-$17.4M |
| 4 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
-$7.25M |
| 5 |
LPL Financial
San Diego,
California
|
-$4.9M |
PJP Hedge Fund Activity: Q3 2015 in Review
106 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2015, worth a combined $318M — down 28% from $440M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of PJP and 9 opened new positions — a net loss of 3 holders — while 41 trimmed existing stakes and 37 added.
The largest buyer was Citadel Advisors, adding an estimated $4.03M. The largest seller was Envestnet Asset Management, cutting an estimated $19.7M.
- 106 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2015, down from 110 in Q2 2015.
- Funds reported $318M of Invesco Pharmaceuticals ETF stock for Q3 2015, down 28% quarter-over-quarter.
- 9 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2015 and 12 closed out, a net change of -3 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q3 2015 was Citadel Advisors, an estimated $4.03M added.
- The largest Invesco Pharmaceuticals ETF seller in Q3 2015 was Envestnet Asset Management, an estimated $19.7M sold.
Based on aggregated 13F filings for Q3 2015.